至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Modulation of Extracellular ISG15 Signaling by Pathogens and Viral Effector Proteins

Cell Rep. 2020-06; 
Caleb D Swaim , Larissa A Canadeo , Kristen J Monte , Swati Khanna , Deborah J Lenschow , Jon M Huibregtse
Products/Services Used Details Operation
Gene Synthesis HEK293T cells were transfected with 100ng of plasmid expressing FLAG-ISG15 or the indicated ISG15 variant, with or without plasmids expressing NS1B (synthesized by GenScript from Influenza B virus B/Yamanashi/166/1998 sequence), ISG15 conjugation components (Ube1L, UbcH8, Herc5), or the indicated vDIG (ERVEV vOTU, FMDV Lbpro, SARS-CoV2 PLpro), using X-tremeGENE HP DNA transfection reagent (Roche).  Get A Quote

摘要

ISG15 is a ubiquitin-like modifier that also functions extracellularly, signaling through the LFA-1 integrin to promote interferon (IFN)-γ release from natural killer (NK) and T cells. The signals that lead to the production of extracellular ISG15 and the relationship between its two core functions remain unclear. We show that both epithelial cells and lymphocytes can secrete ISG15, which then signals in either an autocrine or paracrine manner to LFA-1-expressing cells. Microbial pathogens and Toll-like receptor (TLR) agonists result in both IFN-β-dependent and -independent secretion of ISG15, and residues required for ISG15 secretion are mapped. Intracellular ISGylation inhibits secretion, and viral effector... More

关键词

 ERVE Nairovirus vOTU; ISG15; LFA-1; SARS-CoV-2/COVID-19 PL(pro); TLRs; foot and mouth disease virus Lb(pro); influenza B NS1; interferon-α/β; interferon-γ.